A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

particularly if you keep them up after stopping the drug. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps balance blood sugar (glucose) levels, suppresses appetite ...

Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...

In August 2024, Eli Lilly reduced the price of its GLP-1 Zepbound by almost 50% to compete with knock-offs. It now sells for $399 to $549 a month ... of semaglutide in May 2022. After she achieved ...

Courtesy Staci Rice, Classified as a GLP-1, appetite-suppressing medications, semaglutide is the active ... come and I wouldn’t take it.” After a few months without the drugs, her “food ...